CRISPR Therapeutics AG

NASDAQ:CRSP

42.12 (USD) • At close March 14, 2025
Bedrijfsnaam CRISPR Therapeutics AG
Symbool CRSP
Munteenheid USD
Prijs 42.12
Beurswaarde 3,612,821,940
Dividendpercentage 0%
52-weken bereik 36.52 - 75.91
Industrie Biotechnology
Sector Healthcare
CEO Dr. Samarth Kulkarni Ph.D.
Website https://www.crisprtx.com

Over CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio

Vergelijkbare Aandelen

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

36.12 USD

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

IRTC

100.67 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

143.45 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

19.17 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

24.66 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

125.4 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

324.95 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

101.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)